Home
Screener
ALPN
profile

ALPN Company Profile and Key Details

NASDAQ : ALPN

Alpine Immune Sciences, Inc.

$64.97

0.01+0.02%

At Close 4:00 PM

Not Actively Trading

57.09

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

ALPN Stock Price Chart

Stock Price Today

Alpine Immune Sciences, Inc. (ALPN) stock surged +0.02%, trading at $64.97 on NASDAQ, up from the previous close of $64.96. The stock opened at $64.98, fluctuating between $64.97 and $65.00 in the recent session.

Stock Snapshot

64.96

Prev. Close

64.98

Open

4.46B

Market Cap

68.6M

Number of Shares

64.97

Day Low

Day High

-101.515625

P/E Ratio

69.8%

Free Float in %

-0.64

EPS (TTM)

5.43

Book Value

-1.32

Cash Flow per Share

4.29M

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 17, 2024	64.98	65.00	64.97	64.97	4.28M
May 16, 2024	64.97	64.98	64.95	64.97	563.91K
May 15, 2024	64.95	64.97	64.94	64.97	1.26M
May 14, 2024	64.94	64.96	64.94	64.95	1.05M
May 13, 2024	64.94	64.96	64.92	64.95	2.97M
May 10, 2024	64.94	64.94	64.91	64.94	2.81M
May 09, 2024	64.67	64.85	64.65	64.82	1.14M
May 08, 2024	64.63	64.72	64.59	64.70	747.94K
May 07, 2024	64.60	64.67	64.56	64.64	1.33M
May 06, 2024	64.63	64.64	64.50	64.60	1.37M
May 03, 2024	64.65	64.65	64.58	64.60	1.92M
May 02, 2024	64.62	64.68	64.58	64.60	2.82M
May 01, 2024	64.63	64.69	64.56	64.60	2.76M
Apr 30, 2024	64.63	64.72	64.56	64.59	1.57M
Apr 29, 2024	64.61	64.70	64.57	64.70	1.63M
Apr 26, 2024	64.58	64.63	64.51	64.56	1.33M
Apr 25, 2024	64.57	64.65	64.54	64.62	1.77M
Apr 24, 2024	64.57	64.63	64.56	64.57	1.18M
Apr 23, 2024	64.58	64.70	64.50	64.55	3.1M
Apr 22, 2024	64.52	64.58	64.44	64.58	1.79M

Contact Details

Seattle, WA 98102

United States

Website: https://www.alpineimmunesciences.comContact: 206 788 4545

About Company

Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington.

Frequently Asked Questions

What is the current Alpine Immune Sciences, Inc. (ALPN) stock price?

Alpine Immune Sciences, Inc. (NASDAQ: ALPN) stock price is $64.97 in the last trading session. During the trading session, ALPN stock reached the peak price of $65.00 while $64.97 was the lowest point it dropped to. The percentage change in ALPN stock occurred in the recent session was 0.02% while the dollar amount for the price change in ALPN stock was $0.01.

ALPN's industry and sector of operation?

The NASDAQ listed ALPN is part of Biotechnology industry that operates in the broader Healthcare sector. Alpine Immune Sciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ALPN?

Dr. Remy Durand Ph.D.
Chief Bus. Officer
Mr. Paul Rickey
Senior Vice President, Chief Financial Officer, Treasurer & Sec.
Dr. Pamela Holland Ph.D.
Senior Vice President of Research
Dr. Andrew Seth Sandler M.D.
Chief Medical Officer
Temre Johnson
Head of IR & Corporation Communications
Dr. Wayne R. Gombotz
Chief Technology Officer
Dr. Stanford Peng M.D., Ph.D.
Pres and Head of R&D
Dr. Mitchell H. Gold M.D.
Executive Chairman & Chief Executive Officer

How ALPN did perform over past 52-week?

ALPN's closing price is 679.95% higher than its 52-week low of $8.33 where as its distance from 52-week high of $65.00 is -0.05%.

How many employees does ALPN have?

Number of ALPN employees currently stands at 142.

Link for ALPN official website?

Official Website of ALPN is: https://www.alpineimmunesciences.com

How do I contact ALPN?

ALPN could be contacted at phone 206 788 4545 and can also be accessed through its website. ALPN operates from 188 East Blaine Street, Seattle, WA 98102, United States.

How many shares of ALPN are traded daily?

ALPN stock volume for the day was 4.29M shares. The average number of ALPN shares traded daily for last 3 months was 2.37M.

What is the market cap of ALPN currently?

The market value of ALPN currently stands at $4.46B with its latest stock price at $64.97 and 68.6M of its shares outstanding.

Employees	142
Beta	0.97
Sales or Revenue	$58.88M
5Y Sales Change%	22.132%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology